OP
BIO icon

Oslo Pensjonsforsikring’s Bio-Rad Laboratories Class A BIO Stock Holding History

Oslo Pensjonsforsikring’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-519
Closed -$126K – 466
2025
Q1 		$126K Buy
519
+240
+86% +$72.2K 0.02% 306
2024
Q4 		$91.7K Buy
+279
New +$94.7K 0.01% 346
2024
Q3 		– Sell
-258
Closed -$70.5K – 446
2024
Q2 		$70.5K Buy
+258
New +$75K 0.01% 365

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Veritas Asset Management
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Ariel Investments
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
First Pacific Advisors
First Pacific Advisors El Segundo, California $8.09B AUM 21.95% 1-Year Est. Return

Oslo Pensjonsforsikring's BIO Position: Q2 2025 in Review

Oslo Pensjonsforsikring sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 519 shares — an estimated $126K sold.

Oslo Pensjonsforsikring first reported a position in BIO in Q2 2024 and held it in 3 quarters. The position peaked at $126K in Q1 2025. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

  • Oslo Pensjonsforsikring reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
  • Oslo Pensjonsforsikring sold 519 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $126K.
  • Oslo Pensjonsforsikring first reported a position in Bio-Rad Laboratories Class A in Q2 2024 and held it in 3 quarters.
  • Oslo Pensjonsforsikring's Bio-Rad Laboratories Class A position peaked at $126K in Q1 2025.
  • 384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Oslo Pensjonsforsikring's 13F filing for Q2 2025, filed 13 Oct 2026.